Clinical Trials Directory

Trials / Completed

CompletedNCT00925418

Evaluation of the Cryotherapy in the Prevention of Nails Toxicity Induced by Taxotere® in Breast or Prostate Cancer

Randomized Trial Evaluating the Cryotherapy in the Prevention of Nails Toxicity Induced by Taxotere® in Patient Treated for Breast or Prostate Cancer.

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
168 (estimated)
Sponsor
Institut Paoli-Calmettes · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

Taxotere® can induce nails changes like dyschromia, hematoma, lines of Beau-Reil (signing the stop of the epithelial proliferation), abscess, or pain. In this context, this randomized, monocentric phase III trial evaluates the cryotherapy, using frozen glove, in the prevention of nails toxicity induced by Taxotere® in patient treated for breast or prostate cancer. Primary objective: Demonstrate a reduction of the nails toxicity using frozen glove during chemotherapy with Taxotere®. Secondary objectives: Analysis of time of protection against onycholysis Estimation of the efficiency of cryotherapy, and impact on quality of life Tolerance and compliance of the frozen glove

Conditions

Interventions

TypeNameDescription
PROCEDUREFrozen GloveUsing frozen glove during chemotherapy with Taxotere®

Timeline

Start date
2006-09-01
Primary completion
2010-09-01
Completion
2011-07-01
First posted
2009-06-22
Last updated
2011-09-14

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT00925418. Inclusion in this directory is not an endorsement.